These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 20181277)

  • 1. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
    Paniagua RT; Chang A; Mariano MM; Stein EA; Wang Q; Lindstrom TM; Sharpe O; Roscow C; Ho PP; Lee DM; Robinson WH
    Arthritis Res Ther; 2010; 12(1):R32. PubMed ID: 20181277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis.
    Paniagua RT; Sharpe O; Ho PP; Chan SM; Chang A; Higgins JP; Tomooka BH; Thomas FM; Song JJ; Goodman SB; Lee DM; Genovese MC; Utz PJ; Steinman L; Robinson WH
    J Clin Invest; 2006 Oct; 116(10):2633-42. PubMed ID: 16981009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis.
    Garcia S; Hartkamp LM; Malvar-Fernandez B; van Es IE; Lin H; Wong J; Long L; Zanghi JA; Rankin AL; Masteller EL; Wong BR; Radstake TR; Tak PP; Reedquist KA
    Arthritis Res Ther; 2016 Mar; 18():75. PubMed ID: 27036883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
    Toh ML; Bonnefoy JY; Accart N; Cochin S; Pohle S; Haegel H; De Meyer M; Zemmour C; Preville X; Guillen C; Thioudellet C; Ancian P; Lux A; Sehnert B; Nimmerjahn F; Voll RE; Schett G
    Arthritis Rheumatol; 2014 Nov; 66(11):2989-3000. PubMed ID: 24623505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA).
    Ando W; Hashimoto J; Nampei A; Tsuboi H; Tateishi K; Ono T; Nakamura N; Ochi T; Yoshikawa H
    J Bone Miner Metab; 2006; 24(4):274-82. PubMed ID: 16816921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib.
    Dewar AL; Cambareri AC; Zannettino AC; Miller BL; Doherty KV; Hughes TP; Lyons AB
    Blood; 2005 Apr; 105(8):3127-32. PubMed ID: 15637141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin-2 promotes inflammatory activation of human macrophages and is essential for murine experimental arthritis.
    Krausz S; Garcia S; Ambarus CA; de Launay D; Foster M; Naiman B; Iverson W; Connor JR; Sleeman MA; Coyle AJ; Hamann J; Baeten D; Tak PP; Reedquist KA
    Ann Rheum Dis; 2012 Aug; 71(8):1402-10. PubMed ID: 22730375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors.
    Dewar AL; Domaschenz RM; Doherty KV; Hughes TP; Lyons AB
    Leukemia; 2003 Sep; 17(9):1713-21. PubMed ID: 12970769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals.
    Hiraga T; Nakamura H
    Int J Cancer; 2009 Jan; 124(1):215-22. PubMed ID: 18814279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligation of TLR5 promotes myeloid cell infiltration and differentiation into mature osteoclasts in rheumatoid arthritis and experimental arthritis.
    Kim SJ; Chen Z; Chamberlain ND; Essani AB; Volin MV; Amin MA; Volkov S; Gravallese EM; Arami S; Swedler W; Lane NE; Mehta A; Sweiss N; Shahrara S
    J Immunol; 2014 Oct; 193(8):3902-13. PubMed ID: 25200955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib mesylate both prevents and treats the arthritis induced by type II collagen antibody in mice.
    Koyama K; Hatsushika K; Ando T; Sakuma M; Wako M; Kato R; Haro H; Sugiyama H; Hamada Y; Ogawa H; Nakao A
    Mod Rheumatol; 2007; 17(4):306-10. PubMed ID: 17694264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
    Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
    Front Immunol; 2018; 9():2228. PubMed ID: 30319663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients.
    Kabala PA; Malvar-Fernández B; Lopes AP; Carvalheiro T; Hartgring SAY; Tang MW; Conde C; Baeten DL; Sleeman M; Tak PP; Connor J; Radstake TR; Reedquist KA; García S
    Rheumatology (Oxford); 2020 Feb; 59(2):426-438. PubMed ID: 31377797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis.
    Crespo O; Kang SC; Daneman R; Lindstrom TM; Ho PP; Sobel RA; Steinman L; Robinson WH
    J Clin Immunol; 2011 Dec; 31(6):1010-20. PubMed ID: 21847523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis.
    Akashi N; Matsumoto I; Tanaka Y; Inoue A; Yamamoto K; Umeda N; Tanaka Y; Hayashi T; Goto D; Ito S; Sekiguchi K; Sumida T
    Mod Rheumatol; 2011 Jun; 21(3):267-75. PubMed ID: 21188449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JTE-952 Suppresses Bone Destruction in Collagen-Induced Arthritis in Mice by Inhibiting Colony Stimulating Factor 1 Receptor.
    Uesato N; Inagaki K; Miyagawa N; Kitagawa Y; Kakefuda R; Matsuo Y; Yamaguchi T; Hata T; Ikegashira K; Matsushita M
    Biol Pharm Bull; 2020; 43(12):1884-1892. PubMed ID: 33268706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.
    Conway JG; McDonald B; Parham J; Keith B; Rusnak DW; Shaw E; Jansen M; Lin P; Payne A; Crosby RM; Johnson JH; Frick L; Lin MH; Depee S; Tadepalli S; Votta B; James I; Fuller K; Chambers TJ; Kull FC; Chamberlain SD; Hutchins JT
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):16078-83. PubMed ID: 16249345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells.
    Chang BY; Huang MM; Francesco M; Chen J; Sokolove J; Magadala P; Robinson WH; Buggy JJ
    Arthritis Res Ther; 2011 Jul; 13(4):R115. PubMed ID: 21752263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis.
    Fuentelsaz-Romero S; Cuervo A; Estrada-Capetillo L; Celis R; García-Campos R; Ramírez J; Sastre S; Samaniego R; Puig-Kröger A; Cañete JD
    Front Immunol; 2020; 11():613975. PubMed ID: 33679701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.